Better approach for autoimmune pulmonary alveolar proteinosis treatment: inhaled or subcutaneous granulocyte-macrophage colony-stimulating factor: a meta-analyses

BACKGROUND: Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare pulmonary disease caused by functional deficiency of granulocyte-macrophage colony-stimulating factor (GM-CSF). GM-CSF therapy in aPAP has been reported effective in some studies. This meta-analyses aimed to evaluate whether GM-C...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheng, Gaohong, Chen, Peng, Wei, Yanqiu, Chu, Jiaojiao, Cao, Xiaolei, Zhang, Hui-Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117963/
https://www.ncbi.nlm.nih.gov/pubmed/30165864
http://dx.doi.org/10.1186/s12931-018-0862-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117963/
https://www.ncbi.nlm.nih.gov/pubmed/30165864
http://dx.doi.org/10.1186/s12931-018-0862-4

Ejemplares similares